chr19-49010569-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006666.3(RUVBL2):c.745G>A(p.Val249Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000201 in 1,592,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000047 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
RUVBL2
NM_006666.3 missense
NM_006666.3 missense
Scores
3
5
8
Clinical Significance
Conservation
PhyloP100: 7.25
Genes affected
RUVBL2 (HGNC:10475): (RuvB like AAA ATPase 2) This gene encodes the second human homologue of the bacterial RuvB gene. Bacterial RuvB protein is a DNA helicase essential for homologous recombination and DNA double-strand break repair. Functional analysis showed that this gene product has both ATPase and DNA helicase activities. This gene is physically linked to the CGB/LHB gene cluster on chromosome 19q13.3, and is very close (55 nt) to the LHB gene, in the opposite orientation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.399732).
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUVBL2 | NM_006666.3 | c.745G>A | p.Val249Ile | missense_variant | 9/15 | ENST00000595090.6 | NP_006657.1 | |
RUVBL2 | NM_001321190.2 | c.643G>A | p.Val215Ile | missense_variant | 9/15 | NP_001308119.1 | ||
RUVBL2 | NM_001321191.1 | c.610G>A | p.Val204Ile | missense_variant | 9/15 | NP_001308120.1 | ||
RUVBL2 | NR_135578.2 | n.759G>A | non_coding_transcript_exon_variant | 9/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUVBL2 | ENST00000595090.6 | c.745G>A | p.Val249Ile | missense_variant | 9/15 | 1 | NM_006666.3 | ENSP00000473172 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000467 AC: 7AN: 149966Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
7
AN:
149966
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249438Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135368
GnomAD3 exomes
AF:
AC:
9
AN:
249438
Hom.:
AF XY:
AC XY:
4
AN XY:
135368
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000173 AC: 25AN: 1442392Hom.: 0 Cov.: 39 AF XY: 0.0000195 AC XY: 14AN XY: 717234
GnomAD4 exome
AF:
AC:
25
AN:
1442392
Hom.:
Cov.:
39
AF XY:
AC XY:
14
AN XY:
717234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000467 AC: 7AN: 149966Hom.: 0 Cov.: 30 AF XY: 0.0000684 AC XY: 5AN XY: 73140
GnomAD4 genome
AF:
AC:
7
AN:
149966
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
73140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.745G>A (p.V249I) alteration is located in exon 9 (coding exon 9) of the RUVBL2 gene. This alteration results from a G to A substitution at nucleotide position 745, causing the valine (V) at amino acid position 249 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
Sift4G
Benign
T;T;T
Polyphen
D;.;.
Vest4
MutPred
Gain of helix (P = 0.0082);.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at